These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8427965)

  • 21. In vitro evidence of a tissue factor-independent mode of action of recombinant factor VIIa in hemophilia.
    Augustsson C; Persson E
    Blood; 2014 Nov; 124(20):3172-4. PubMed ID: 25232061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue factor-dependent pathway in severe preeclampsia revisited: a Brazilian cohort study.
    Dusse LM; Godoi LC; Gomes KB; Carvalho Md; Lwaleed BA
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):436-40. PubMed ID: 26765308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
    Reuning U; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
    Moor E; Silveira A; van't Hooft F; Suontaka AM; Eriksson P; Blombäck M; Hamsten A
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):655-64. PubMed ID: 7749878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of heparin and its neutralisation on functional assays for factor VIIa, factor VII and TFPI.
    Cardigan RA; Mackie IJ; Machin SJ
    Thromb Res; 1996 Nov; 84(4):237-42. PubMed ID: 8948048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance.
    Björquist P; Boström S
    Thromb Res; 1997 Feb; 85(3):225-36. PubMed ID: 9058497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor VII activation and oral contraceptives.
    Plu-Bureau G; Scarabin PY; Bara L; Malmejac A; Guize L; Samama M
    Thromb Res; 1993 May; 70(3):275-80. PubMed ID: 8327993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations.
    Bernardi F; Arcieri P; Bertina RM; Chiarotti F; Corral J; Pinotti M; Prydz H; Samama M; Sandset PM; Strom R; Garcia VV; Mariani G
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2548-53. PubMed ID: 9409226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method.
    Halabian R; Roudkenar MH; Esmaeili NS; Masroori N; Roushandeh AM; Najafabadi AJ
    Vox Sang; 2009 May; 96(4):309-15. PubMed ID: 19175565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age- and sex-related differences of plasma activated factor VII levels in children.
    Sakata T; Yamamura T; Kario K; Katayama Y; Matsuyama T; Kato H; Yamamoto A; Miyata T
    Thromb Haemost; 1999 Jun; 81(6):910-2. PubMed ID: 10404766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low plasma FVII:C and activated FVII as predictive markers for overt disseminated intravascular coagulation.
    Lertthammakiat S; Anantasit N; Anurathapan U; Sirachainan N; Kadegasem P; Chuansumrit A
    Thromb Haemost; 2017 Jul; 117(8):1471-1477. PubMed ID: 28492702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor VIIa replacement therapy in factor VII deficiency.
    Brummel Ziedins K; Rivard GE; Pouliot RL; Butenas S; Gissel M; Parhami-Seren B; Mann KG
    J Thromb Haemost; 2004 Oct; 2(10):1735-44. PubMed ID: 15456484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
    Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
    Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two naturally occurring mutations on FVII gene (S363I-W364C) altering intrinsic catalytic activity.
    Peyvandi F; De Cristofaro R; Akhavan S; Carew JA; Landolfi R; Bauer KA; Mannucci PM
    Thromb Haemost; 2002 Nov; 88(5):750-5. PubMed ID: 12428089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of coagulation factor VII by tissue-type plasminogen activator.
    Tsujioka H; Suehiro A; Kakishita E
    Am J Hematol; 1999 May; 61(1):34-9. PubMed ID: 10331509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary factor VII activation does not increase plasma concentrations of prothrombin fragment 1+2 in patients with stable angina pectoris and coronary atherosclerosis.
    Bladbjerg EM; Münster AM; Marckmann P; Keller N; Jespersen J
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2494-9. PubMed ID: 11073858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. possible implications for measurements in vivo after heparin therapy.
    Bladbjerg EM; Larsen LF; Ostergaard P; Jespersen J
    Blood Coagul Fibrinolysis; 2000 Dec; 11(8):739-45. PubMed ID: 11132652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity.
    Neuenschwander PF; Morrissey JH
    J Biol Chem; 1992 Jul; 267(20):14477-82. PubMed ID: 1629232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor VII in plasma of women taking oral contraceptives. Lack of cold activation under blood bank conditions.
    Seligsohn U; Zivelin A; Zwang E; Bar-Shani S
    Transfusion; 1984; 24(2):171-2. PubMed ID: 6608809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q).
    O'Brien DP; Kemball-Cook G; Hutchinson AM; Martin DM; Johnson DJ; Byfield PG; Takamiya O; Tuddenham EG; McVey JH
    Biochemistry; 1994 Nov; 33(47):14162-9. PubMed ID: 7947828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.